Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Rapid evidence summary on SARS-CoV-2 surface survival and efficacy of ozone machines against SARS-CoV-2

Rapid evidence summary on SARS-CoV-2 surface survival and efficacy of ozone machines against SARS-CoV-2

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Declining immune responses against SARS-CoV-2 variants in dialysis patients post-vaccination

Declining immune responses against SARS-CoV-2 variants in dialysis patients post-vaccination

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

Cell-mediated immune response among inflammatory bowel disease patients after mRNA COVID-19 vaccination

Cell-mediated immune response among inflammatory bowel disease patients after mRNA COVID-19 vaccination

Application of various nanoparticle-capsulated siRNA as therapeutics for SARS-CoV-2 infection

Application of various nanoparticle-capsulated siRNA as therapeutics for SARS-CoV-2 infection

Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers

Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers

Study identifies higher infection rate and lower disease severity during Omicron wave in US

Study identifies higher infection rate and lower disease severity during Omicron wave in US

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

Should SARS-CoV-2 Omicron be considered a serotype?

Should SARS-CoV-2 Omicron be considered a serotype?

COVID-19's impact on the hopes and dreams of Australians

COVID-19's impact on the hopes and dreams of Australians

A comparison of COVID-19 vaccines by neutralizing antibody potency

A comparison of COVID-19 vaccines by neutralizing antibody potency

Melatonin as a safe and potentially life-saving treatment for COVID-19

Melatonin as a safe and potentially life-saving treatment for COVID-19

Study explores the boosting of SARS-CoV-2 adenovirus vaccine-induced immunity by capsid decoration

Study explores the boosting of SARS-CoV-2 adenovirus vaccine-induced immunity by capsid decoration

Foundational characterization of a new bat-borne ebolavirus and its potential as a human pathogen

Foundational characterization of a new bat-borne ebolavirus and its potential as a human pathogen

Study finds two doses of COVID-19 vaccines were insufficient to neutralize the SARS-CoV-2 Omicron variant

Study finds two doses of COVID-19 vaccines were insufficient to neutralize the SARS-CoV-2 Omicron variant

Third dose of mRNA-based COVID-19 vaccine efficiently recalls Omicron-reactive B cell memory

Third dose of mRNA-based COVID-19 vaccine efficiently recalls Omicron-reactive B cell memory

Study reports persistent SARS-CoV-2 lingering within tissues of patients with long COVID

Study reports persistent SARS-CoV-2 lingering within tissues of patients with long COVID

Metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 Delta, Alpha, and Omicron variants

Metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 Delta, Alpha, and Omicron variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.